Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy

NCT03832660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Hypertrophic Cardiomyopathy

Interventions

BEHAVIORAL: Lifestyle
DRUG: Sacubitril/Valsartan

Sponsor

Newcastle University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]